Related Experiment Video
Updated: Aug 28, 2025

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Patients With Larger Left Atrial Appendage Orifice Presented Worse Prognosis Contributed by Acute Heart Failure After
Zhongyuan Ren1, Yixing Zheng1, Jingying Zhang1
1Heart Center, Shanghai Tenth People's Hospital, School of Medicine Tongji University Shanghai China.
Insights
Left atrial appendage closure (LAAC) for atrial fibrillation patients with larger LAA orifices shows a worse prognosis, including increased acute heart failure risk. Larger LAA size predicts adverse events, except in specific patient subgroups.
Area of Science:
- Cardiology
- Medical Devices
- Clinical Outcomes
Background:
- Left atrial appendage closure (LAAC) prevents stroke in atrial fibrillation but may compromise left atrial compliance and patient prognosis.
- The impact of left atrial appendage (LAA) orifice size on post-LAAC outcomes requires further investigation.
Purpose of the Study:
- To comparatively evaluate the prognosis of LAAC in patients stratified by LAA orifice size.
- To identify LAA orifice size as a predictor of adverse clinical events following LAAC.
Main Methods:
- 302 patients undergoing successful LAAC were categorized into four groups based on LAA orifice size measured by transesophageal echocardiography.
- Clinical outcomes including thromboembolic events, major cardiocerebrovascular adverse events, and acute heart failure (AHF) were analyzed.
- Propensity-score matching was used to compare outcomes between large and small LAA orifice groups.
Main Results:
- Thromboembolic event survival was similar across groups.
- The largest LAA orifice group exhibited significantly lower survival for major cardiocerebrovascular adverse events (P<0.001), with a higher incidence of AHF (NYHA class III-IV, 21.4%, P=0.009).
- A large LAA orifice predicted major cardiocerebrovascular adverse events (HR, 3.749), except in younger patients, those with paroxysmal atrial fibrillation, or failed rhythm/rate control.
Conclusions:
- Larger LAA orifice size is associated with a worse prognosis after LAAC, characterized by increased AHF incidence.
- LAA orifice size serves as a predictor for post-LAAC AHF events in most patients, with exceptions noted for specific subgroups.
Abstract:
Background Left atrial appendage (LAA) closure (LAAC) could prevent stroke in patients with atrial fibrillation. However, LAAC may impair the compliance of the left atrium and result in poor prognosis. This study aimed to comparatively evaluate the prognosis of LAAC among patients with different sizes of LAA orifice. Methods and Results Three hundred two consecutive patients who underwent successful LAAC were included and divided into 4 groups based on LAA orifice size that was measured using transesophageal echocardiography. Clinical outcomes including thromboembolic events, major cardiocerebrovascular adverse events, and acute heart failure (AHF) were compared among 4 quartile groups and between propensity-score matched groups of large and small LAAs. Through follow-up of 39.6±8.4 months, survival of thromboembolic events was similar. Survival of major cardiocerebrovascular adverse events was significantly lower in the group with the largest LAA orifice (log-rank P<0.001), including a higher incidence of AHF with New York Heart Association class III to IV (21.4%, log-rank P=0.009). A large LAA orifice (by cutoff) could predict major cardiocerebrovascular adverse events (hazard ratio, 3.749 [95% CI, 2.074-6.779]) in most patients, except for subgroups of those aged <65 years, with paroxysmal atrial fibrillation, and/or with failed rhythm/rate control. Further compared with a propensity-score matched small-LAA group, the large-LAA orifice group still presented worse survival of AHF with New York Heart Association class III to IV (log-rank P=0.010). Conclusions Patients with a larger LAA orifice presented a worse prognosis after LAAC, including a higher incidence of AHF. A large LAA orifice could predict a post-LAAC AHF event in most patients, except for young patients, patients with paroxysmal atrial fibrillation, and/or with failed rhythm/rate control. Registration URL: clinicaltrials.gov; Unique identifier: NCT04185142.
Related Concept Videos
Aortic Regurgitation III: Medical Management
Aortic Regurgitation I: Introduction
Aneurysm III: Interprofessional Care

